Therefore, we hypothesized that LKB1 acts as a tumor suppressor by increasing cell vulnerability to DSBs in the normal environment; however, in the presence of gemcitabine, other mechanisms were activated in LKB1-transfected cells to eliminate this vulnerability to DSBs. This evidence concerns the gene STK11 and neoplasm.